ATREVIA® 360°, THE COMPREHENSIVE CANINE PARASITE PROTECTION, ARRIVES IN EL SALVADOR.

El Salvador, January 2026. This country was the setting for the launch of Atrevia® 360°, the new, state-of-the-art oral antiparasitic that is revolutionizing the pet market by setting a new standard in comprehensive ecto-endoparasitic protection.
Petmedica®, in collaboration with its strategic partner MONTECO ANIMAL HEALTH S.A. DE C.V., held the official product presentation in the cities of San Miguel and San Salvador. The event was a great success, with more than 200 attendees, including veterinarians, clinic owners, animal health professionals, and members of the media. The main objective was to formally introduce the value proposition of Atrevia® 360° to the Salvadoran market.
The technical presentation was given by Dr. Luis Alfredo Chávez Balarezo, Technical Commercial Manager of Petmedica®, who detailed the product's main attributes and mechanism of action, generating significant interest due to the efficacy and convenience offered by this new solution.
The event also marked the launch of the new Atrevia® campaign, "Love Cares," which celebrates the bond with our pets alongside the renowned artist Chayanne. With this initiative, Petmedica seeks to strengthen its relationship with pet owners, ensuring a positive impact and great success in the country.
Petmedica® thanks the Salvadoran veterinary community for the excellent reception and reaffirms its commitment to continue developing innovative veterinary solutions that improve the quality of life of animals.
For more information about the complete product line, please visit: www.atrevia.vet.